Pathogen-resistant animals having modified CD163 genes

US10827730B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10827730-B2
Application numberUS-201615750633-A
CountryUS
Kind codeB2
Filing dateJul 22, 2016
Priority dateAug 6, 2015
Publication dateNov 10, 2020
Grant dateNov 10, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Non-human animals and offspring thereof comprising at least one modified chromosomal sequence in a gene encoding a CD163 protein are provided. Animal cells that contain such modified chromosomal sequences are also provided. The animals and cells have increased resistance to pathogens, including porcine reproductive and respiratory syndrome virus (PRRSV). The animals and offspring have chromosomal modifications of a CD163 gene. The invention further relates to methods of breeding to create pathogen-resistant animals and populations of animals made using such methods.

First claim

Opening claim text (preview).

What is claimed is: 1. A porcine animal or offspring thereof whose genome comprises a deletion within a gene encoding a CD163 protein, said deletion selected from the group consisting of: a 1280 base pair deletion from nucleotide 2,818 to nucleotide 4,097 as compared to reference sequence SEQ ID NO: 47; a 1467 base pair deletion from nucleotide 2,431 to nucleotide 3,897 as compared to reference sequence SEQ ID NO: 47; wherein said deletion results in lack of detectable surface expression of CD163 protein on alveolar macrophages, and wherein when the animal or offspring is infected with either a Type 1 or Type 2 porcine reproductive and respiratory syndrome (PRRS) virus, the animal or offspring is negative for viremia and does not seroconvert. 2. The porcine animal or offspring of claim 1 , wherein the animal or offspring comprises a chromosomal sequence having at least 80% sequence identity to SEQ ID NO: 47 in the regions of said chromosomal sequence outside of the deletion. 3. The porcine animal or offspring of claim 1 , wherein the animal or offspring comprises a chromosomal sequence comprising SEQ ID NO: 100 or 109. 4. The animal or offspring of claim 1 , wherein the deletion reduces the susceptibility of the animal or offspring to a Type 1 PRRS virus, a Type 2 PRRS virus, or to both Type 1 and Type 2 PRRS viruses. 5. The animal or offspring of claim 4 , wherein the deletion reduces the susceptibility of the animal or offspring to a PRRS virus isolate selected from the group consisting of NVSL 97-7895, KS06-72109, P129, VR2332, CO90, AZ25, MLV-ResPRRS, KS62-06274, KS483 (SD23983), CO84, SD13-15, Lelystad, 03-1059, 03-1060, SD01-08, 4353PZ, and combinations thereof. 6. The animal or offspring of claim 1 , wherein the animal has been genetically edited using a homing endonuclease, and the homing endonuclease comprises a Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system, a Transcription Activator-Like Effector Nuclease (TALEN), a Zinc Finger Nuclease (ZFN), a recombinase fusion protein, a meganuclease, or a combination thereof. 7. The animal or offspring of claim 6 , wherein the animal has been genetically edited using a CRISPR/Cas9 system. 8. The animal or offspring of claim 1 , wherein the deletion causes CD163 protein production or activity to be reduced, as compared to CD163 protein production or activity in an animal or offspring that lacks the deletion. 9. An isolated cell obtained from the porcine animal or offspring thereof of claim 1 . 10. The isolated cell of claim 9 , wherein said cell is a sperm cell or an egg cell. 11. The isolated cell of claim 10 , wherein said egg cell is a fertilized egg. 12. The isolated cell of claim 9 , wherein said cell is a somatic cell.

Assignees

Inventors

Classifications

  • Ribonucleases {[RNase]; Deoxyribonucleases [DNase]} · CPC title

  • Breeding vertebrates · CPC title

  • Cells modified by introduction of foreign genetic material · CPC title

  • Oocytes, oogonia (fertilised oocytes C12N5/0604) · CPC title

  • Sperm cells, spermatogonia · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10827730B2 cover?
Non-human animals and offspring thereof comprising at least one modified chromosomal sequence in a gene encoding a CD163 protein are provided. Animal cells that contain such modified chromosomal sequences are also provided. The animals and cells have increased resistance to pathogens, including porcine reproductive and respiratory syndrome virus (PRRSV). The animals and offspring have chromosom…
Who is the assignee on this patent?
Univ Missouri
What technology area does this patent fall under?
Primary CPC classification A01K67/0276. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Nov 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).